Abstract

Frederick Sanger was an eminent British biochemist whose work revolutionized molecular biology and laid the foundation for modern genetics. He is unique in being awarded the Nobel Prize in Chemistry twice, highlighting the exceptional significance of his scientific contributions. Sanger’s first landmark achievement was the determination of the complete amino acid sequence of insulin in 1955. This was the first protein to be fully sequenced, conclusively demonstrating that proteins possess a precise and ordered chemical structure. This discovery disproved the earlier belief that proteins were random aggregates and established the molecular basis of protein synthesis under genetic control. Sanger’s work on insulin had profound implications for medicine, particularly in understanding diabetes mellitus and enabling the large-scale synthesis of insulin for therapeutic use. It also introduced systematic techniques for sequencing proteins, which became fundamental tools in biochemistry and molecular biology. His second major contribution transformed genetics entirely. In 1977, Sanger developed the dideoxy chain-termination method for DNA sequencing, widely known as Sanger sequencing. This technique enabled accurate determination of nucleotide sequences by incorporating chain- terminating dideoxynucleotides during DNA replication. The method was reliable, reproducible, and relatively simple, leading to its rapid adoption worldwide. For several decades, it remained the gold standard for DNA sequencing. Sanger sequencing played a pivotal role in decoding viral, bacterial, and eukaryotic genomes and was instrumental in the Human Genome Project. Its applications in medicine include identification of genetic mutations, diagnosis of inherited disorders, advances in cancer genetics, prenatal diagnosis, and development of targeted therapies. Beyond his scientific achievements, Frederick Sanger was known for his humility, methodological rigor, and focus on experimental accuracy rather than personal acclaim. His discoveries continue to underpin modern biomedical research, making him one of the most influential scientists in the history of molecular biology.

• 1.   Sanger F., Nicklen S., Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Sciences of the United States of America. 1977; 74(12): 5463-5467.
• 2.   Sanger F., Air G.M., Barrell B.G., et al. Nucleotide sequence of bacteriophage phi X 174 DNA. Nature. 1977; 265(5596): 687-695.
• 3.   Sanger F., Coulson A.R. A rapid method for determining sequences in DNA by primed syn- thesis with DNA polymerase. Journal of Molecular Biology. 1975; 94(3): 441-448.
• 4.   Sanger F., Tuppy H. The amino-acid sequence in the phenylalanyl chain of insulin. Biochemical Journal. 1951; 49(4): 463-481.
• 5.   International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature. 2004; 431(7011): 931-945.
• 6.   Heather J.M., Chain B. The sequence of sequencers: The history of sequencing DNA. Ge- nomics. 2016; 107(1): 1-8.
• 7.   Sanger F. Sequences, sequences, and sequences. Annual Review of Biochemistry. 1988; 57: 1-28.
• 8.   Brownlee G.G. Frederick Sanger (1918–2013). Biographical Memoirs of Fellows of the Royal Society. 2015.

Data Sharing Statement

Funding